Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitors

Details for Australian Patent Application No. 2008312631 (hide)

Owner Wyeth LLC

Inventors Ayral-Kaloustian, Semiramis; Curran, Kevin Joseph; Verheijen, Jeroen Cunera; Zask, Arie; Kaplan, Joshua Aaron; Richard, David James

Agent Shelston IP

Pub. Number AU-A-2008312631

PCT Pub. Number WO2009/052145

Priority 60/980,332 16.10.07 US; 61/027,595 11.02.08 US

Filing date 15 October 2008

Wipo publication date 23 April 2009

International Classifications

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 May 2010 PCT application entered the National Phase

  PCT publication WO2009/052145 Priority application(s): WO2009/052145

8 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008312635-Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof

2008312624-Preparation of dihydrothieno [3, 2-D] pyrimidines and intermediates used therein